Men's Health Women's Health Senior's Health Antioxidants Sports Nutrition Diet & Weight Loss Vitamins & Minerals Herbs Specialty Supplements Targeted Supplements Spa Products Anti-Aging Basics Body Systems Body Structure Book Store Pet Health My Recommendation My Favorite Articles Our Most Popular Specials Bargain Basement Brands

MSM

Health News Archive 571 - Alzheimer's Disease
<<back to structure/function index

Beta-Carotene Protects Certain People Against Alzheimer's

High levels of the carotenoid beta-carotene may protect cognitive decline in people with a certain genotype that is said to increase the risk of Alzheimer's.  Among high-functioning older persons, antioxidants and beta-carotene in particular may offer protection from cognitive decline in persons with greater genetic susceptibility, wrote lead author Peifeng Hu in the Journal of Gerontology.

Cognitive performance declines naturally with age, but genetics plays a part in the complex progression of Alzheimer's. In 1993 scientists reported that people with a gene that codes for the blood lipoprotein, apolipoprotein E4 (apoE4) have a higher risk of developing Alzheimer's disease at an earlier age than people with apoE2 or apoE3.

The new study, by researchers at UCLA School of Medicine, the University of Southern California, and the National Institute on Aging, used data from a seven-year cohort study of older people to investigate if serum beta-carotene levels had an effect on cognitive decline in people with differing ApoE 4 genotypes (homo- or heterozygous).

Out of the sample population of 455 people, the researchers report that nine people were ApoE4 homozygous, and 97 were ApoE4 heterozygous. Serum beta-carotene levels were measured at baseline, and cognitive function assessed using a 9-item Short Portable Mental Status Questionnaire (SPMSQ).

During the seven years of follow-up, cognitive decline (as measured by falling SPMSQ scores) was documented in 249 people. Hu and co-workers reported that the presence of at least one ApoE 4 allele was linked to a higher risk and larger decline in SPMSQ scores.

The researchers report that high serum beta-carotene levels was associated with a 89 per cent reduction in the risk of cognitive decline in people with at least one APOE 4 allele. For those with no ApoE4 alleles, high serum beta-carotene levels were associated with only a modest 11 per cent reduction in the risk of cognitive decline.

Although the mechanism of Alzheimer's is not clear, more support is gathering for the build-up of plaque from beta-amyloid deposits. The deposits are associated with an increase in brain cell damage and death from oxidative stress. It is against the oxidative stress that beta-carotene may offer protection.

Alzheimer's is the most common form of dementia and currently affects over 13 million people worldwide. The direct and indirect cost of Alzheimer care is over $100 billion in the US alone.

Source: P. Hu, P. Bretsky, E.M. Crimmins, J.M. Guralnik, D.B. Reuben and T.E. Seeman. Association Between Serum Beta-Carotene Levels and Decline of Cognitive Function in High-Functioning Older Persons With or Without Apolipoprotein E 4 Alleles: MacArthur Studies of Successful Aging The Journals of Gerontology Series A: Biological Sciences and Medical Sciences; Volume 61, Pages 616-620.

back to top